StonvexLoading…
StonvexStonvexStonvexCore line items from JKHY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.90B | $1.26B | $644.74M | $2.38B |
Operating Income | $498.26M | $343.21M | $184.06M | $568.72M |
Net Income | $391.55M | $268.65M | $143.99M | $455.75M |
EPS (Diluted) | $5.41 | $3.70 | $1.97 | $6.24 |
Total Assets | $3.05B | $3.06B | $3.05B | $3.04B |
Total Liabilities | $915.75M | $856.99M | $874.24M | $913.14M |
Cash & Equivalents | $20.57M | $28.22M | $36.24M | $101.95M |
Free Cash Flow OCF − CapEx | $412.67M | $243.16M | $111.71M | $588.15M |
Shares Outstanding | 72.43M | 72.66M | 72.91M | 73.05M |